Connect with us

Technology

Australian biotech, EnGeneIC, develops world-first nanocellular anti-COVID-19 vaccine that defeats mutant viruses and – GlobeNewswire

Works against mutant strains including DeltaNo need for refrigeration during transport and storage No added stabilisers or chemicals…

Published

on

Article feature image

  • Works against mutant strains including Delta
  • No need for refrigeration during transport and storage
  • No added stabilisers or chemicals
  • Safety and immune response clinical trial recruiting now in Melbourne
  • Efficacy trial planned for USA

SYDNEY and NEW YORK,…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending